Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Sun Yat-sen University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Beijing Fresenius Kabi Pharmaceutical Co
Information provided by:
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01255020
First received: August 11, 2010
Last updated: June 27, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)